Warth et al. (16) investigated the expression levels of Ki-67 in 417 patients with stages I–IV NSCLC, with cutoff values of Ki-67 set at 25% (lung adenocarcinoma, LUAD) and 50% (lung squamous cell carcinoma, LCSC). This evidence concerns the gene MKI67 and lung adenocarcinoma.